Aptus Pharma
Aptus Pharma Share Price Chart
Aptus Pharma last traded at ₹442.45 (2026-10-13). Over the past month the stock moved +32.8%, three months the stock moved +148.6%, year the stock moved +1098.4%. Its closing range over 52 weeks is ₹37.10 – ₹442.45, with the latest close at its 52-week high.
Closing prices up to 2026-10-13.
About Aptus Pharma
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations.[1]
Business Profile[1] Aptus Pharma Limited is a Gujarat-based marketer and distributor of pharmaceutical formulations, operating in an asset-light model through contract manufacturing partners. It offers a diverse portfolio of 194 products across multiple therapeutic categories.
Fundamentals
Quarterly Results
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 32.20 | 4.50 | 13.98 | 2.87 | 1.67 |
| Sep 2025 | 14.38 | 2.93 | 20.38 | 1.75 | 1.02 |
| Mar 2025 | 14.80 | 2.87 | 19.39 | 1.79 | 1.43 |
| Sep 2024 | 9.76 | 1.98 | 20.29 | 1.31 | 5.24 |
Annual Financials
In the latest year (Mar 2026), Aptus Pharma reported sales of ₹46.57 crore (+89.6%) and net profit of ₹4.62 crore (+49.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 46.57 | 7.45 | 16.00 | 4.62 | 6.73 |
| Mar 2025 | 24.56 | 4.85 | 19.75 | 3.10 | 6.20 |
| Mar 2024 | 17.81 | 1.54 | 8.65 | 0.80 | 26.67 |
| Mar 2023 | 13.90 | 0.62 | 4.46 | 0.19 | 6.33 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | +28.1% | +37.9% | +89.6% |
| Operating profit growth | +148.4% | +214.9% | +53.6% |
| Net profit growth | +321.1% | +287.5% | +49.0% |
| EPS growth | +321.3% | -76.8% | +8.5% |
| OPM % | 8.7% | 19.8% | 16.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Aptus Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
Aptus Pharma enters into Urology therapy segment
-
Aptus Pharma enters into Urology therapy segment
-
Aptus Pharma enters into Urology therapy segment
-
Aptus Pharma enters into Urology therapy segment
Frequently Asked Questions
What is the share price of Aptus Pharma today?
Aptus Pharma shares were last quoted at ₹442.45 (+5.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Aptus Pharma?
Aptus Pharma has a price-to-earnings (P/E) ratio of 129.00 and a price-to-book (P/B) ratio of 25.50. The industry P/E is 29.79.
What is the 52-week high and low of Aptus Pharma?
The 52-week high of Aptus Pharma is ₹365.50 and the 52-week low is ₹32.32.
What is the market cap of Aptus Pharma?
The market capitalisation of Aptus Pharma is about ₹595.11 crore.
Is Aptus Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Aptus Pharma has a 3-year ROE of 41.00%, 3-year profit growth of 190.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Aptus Pharma?
Promoters hold about 72.89% of Aptus Pharma.
Which sector does Aptus Pharma belong to?
Aptus Pharma belongs to the Pharmaceuticals & Drugs sector.